These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38448223)

  • 1. 'The world was going through what we go through everyday': The experiences of women with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) living with their partners during the COVID-19 lockdown in the United Kingdom.
    Sehmbi T; Wearden A; Peters S; Dienes K
    Br J Health Psychol; 2024 Sep; 29(3):629-643. PubMed ID: 38448223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study.
    Weigel B; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    Qual Life Res; 2024 Sep; 33(9):2489-2507. PubMed ID: 38961009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection.
    Unger ER; Lin JS; Wisk LE; Yu H; L'Hommedieu M; Lavretsky H; Montoy JCC; Gottlieb MA; Rising KL; Gentile NL; Santangelo M; Venkatesh AK; Rodriguez RM; Hill MJ; Geyer RE; Kean ER; Saydah S; McDonald SA; Huebinger R; Idris AH; Dorney J; Hota B; Spatz ES; Stephens KA; Weinstein RA; Elmore JG;
    JAMA Netw Open; 2024 Jul; 7(7):e2423555. PubMed ID: 39046739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in adults: a qualitative study of perspectives from professional practice.
    Horton SM; Poland F; Kale S; Drachler Mde L; de Carvalho Leite JC; McArthur MA; Campion PD; Pheby D; Nacul L
    BMC Fam Pract; 2010 Nov; 11():89. PubMed ID: 21078171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
    Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
    JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Children's experiences of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review and meta-ethnography of qualitative studies.
    Parslow RM; Harris S; Broughton J; Alattas A; Crawley E; Haywood K; Shaw A
    BMJ Open; 2017 Jan; 7(1):e012633. PubMed ID: 28087544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences of daily activity in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their implications for rehabilitation programmes.
    Pemberton S; Cox DL
    Disabil Rehabil; 2014; 36(21):1790-7. PubMed ID: 24369769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot cross-sectional investigation of symptom clusters and associations with patient-reported outcomes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 Condition.
    Weigel B; Eaton-Fitch N; Thapaliya K; Marshall-Gradisnik S
    Qual Life Res; 2024 Dec; 33(12):3229-3243. PubMed ID: 39361124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Campen CLMCV; Rowe PC; Visser FC
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.
    Simani L; Ramezani M; Darazam IA; Sagharichi M; Aalipour MA; Ghorbani F; Pakdaman H
    J Neurovirol; 2021 Feb; 27(1):154-159. PubMed ID: 33528827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.
    Wong TL; Weitzer DJ
    Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33925784
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: A cross-sectional survey.
    Wood MS; Halmer N; Bertolli J; Amsden LB; Nugent JR; Lin JS; Rothrock G; Nadle J; Chai SJ; Cope JR; Champsi JH; Yang J; Unger ER; Skarbinski J;
    PLoS One; 2024; 19(9):e0309810. PubMed ID: 39292671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to educational adaptations and social life at school experienced by young people with CFS/ME: a qualitative study.
    Similä WA; Nøst TH; Helland IB; Rø TB
    BMJ Open; 2021 Nov; 11(11):e051094. PubMed ID: 34794992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study.
    Lacerda EM; McDermott C; Kingdon CC; Butterworth J; Cliff JM; Nacul L
    Health Expect; 2019 Jun; 22(3):373-384. PubMed ID: 30632248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lv Y; Zhang T; Cai J; Huang C; Zhan S; Liu J
    Front Immunol; 2022; 13():952987. PubMed ID: 36189286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of school in the management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): issues identified by adolescents and their families.
    Clery P; Linney C; Parslow R; Starbuck J; Laffan A; Leveret J; Crawley E
    Health Soc Care Community; 2022 Nov; 30(6):e5234-e5244. PubMed ID: 35996850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
    Retornaz F; Rebaudet S; Stavris C; Jammes Y
    J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social support needs for equity in health and social care: a thematic analysis of experiences of people with chronic fatigue syndrome/myalgic encephalomyelitis.
    de Carvalho Leite JC; de L Drachler M; Killett A; Kale S; Nacul L; McArthur M; Hong CS; O'Driscoll L; Pheby D; Campion P; Lacerda E; Poland F
    Int J Equity Health; 2011 Nov; 10():46. PubMed ID: 22044797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
    Preßler H; Machule ML; Ufer F; Bünger I; Li LY; Buchholz E; Werner C; Beraha E; Wagner F; Metz M; Burock S; Bruckert L; Franke C; Wilck N; Krüger A; Reshetnik A; Eckardt KU; Endres M; Prüss H
    Trials; 2024 Mar; 25(1):172. PubMed ID: 38454468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.